Joaquim Calbó

1.4k citations
23 papers · 1.1k indexed · h-index 17
Topics
Cancer-related Molecular Pathways (10 papers)Cancer Research and Treatments (7 papers)Virus-based gene therapy research (5 papers)

In The Last Decade

Joaquim Calbó

23 papers receiving 1.0k citations

Peers

Joaquim Calbó
Comparison fields: 5 of 97
  • Molecular Biology 540
  • Oncology 463
  • Epidemiology 161
  • Physiology 143
  • Cancer Research 127
Replace Natalia V. Oleinik with:
Natalia V. Oleinik United States
Sharmistha Chakraborty United States
Ceri Oldreive United Kingdom
Carmela Ciccarelli Italy
William J. Placzek United States
Karen S. Yee United States
Takako Ohsawa Japan
Glenn S. Belinsky United States
Leisl Packer Australia
Deyong Jia China
Joaquim Calbó relative to Natalia V. Oleinik United States Natalia V. Oleinik's profile →
Citations per field
00.5×1.5×2.4×
Natalia V. Oleinik · 1×
Citations per year

Countries citing papers authored by Joaquim Calbó

Since Specialization
Citations

This map shows the geographic impact of Joaquim Calbó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joaquim Calbó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joaquim Calbó more than expected).

Fields of papers citing papers by Joaquim Calbó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joaquim Calbó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joaquim Calbó. The network helps show where Joaquim Calbó may publish in the future.

Co-authorship network of co-authors of Joaquim Calbó

This figure shows the co-authorship network connecting the top 25 collaborators of Joaquim Calbó. A scholar is included among the top collaborators of Joaquim Calbó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joaquim Calbó. Joaquim Calbó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 71
3 9
4 76
5 19
6 77
7 258
8 37
9 30
10 17
11 31
12 16
13 10
14 18
15 11
16 88
17 72
18 8
19 28
20 35

About Joaquim Calbó

Joaquim Calbó is a scholar working on Biotechnology, Oncology and Rheumatology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Cancer Research and Treatments (7 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Oncology (463 citations), Cancer Research (127 citations) and Molecular Biology (540 citations). Joaquim Calbó has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Joan J. Guinovart, Anton Berns, Ralph Meuwissen, Erwin van Montfort, Xavier Graña, Judit Garriga, Natalie Proost, Ellen van Drunen, H. Berna Beverloo and Mar Garcı́a-Rocha. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026